| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 890.4K | $40.16M | - | |
| CEO | 875.0K | $39.46M | - | |
| Other | 740.2K | $33.38M | - | |
| 10% | 245.7K | $11.08M | -281,408 | |
| COO | 215.0K | $9.70M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | Heyman Richard A.74 | Director | Sell | 1,270 | $21.48 | $27,277.95 | -0.9% | +3.8% | +1.1% | |
| Jun 6, 2024 | Patel Anish54 | Chief Operating Officer | Sale+OE | 1,133 | $20.06 | $22,722.43 | -100% | +7.6% | +2.7% | |
| May 29, 2024 | Lyssikatos Joseph P50 | Chief Scientific Officer | Sale+OE | 12,000 | $21.73 | $260,800.14 | -85.0% | +5.8% | -16.8% | |
| May 28, 2024 | Hohl Benjamin60 | Chief Financial Officer | Sale+OE | 4,250 | $23.18 | $98,530.29 | -64.4% | -1.2% | -30.8% | |
| May 28, 2024 | Kintz Samuel51 | President And CEO | Sale+OE | 12,000 | $23.18 | $278,210.05 | -68.9% | -1.2% | -30.8% | |
| May 16, 2024 | Heyman Richard A.74 | Director | Sell | 1,270 | $23.74 | $30,149.67 | -0.9% | -8.4% | -29.2% | |
| May 16, 2024 | Gupta Rishi | Director, 10% Owner | Sell | 1,033,300 | $22.14 | $22,877,262.00 | -11.5% | -8.4% | -29.2% | |
| May 16, 2024 | Orbimed Advisors LLC67 | Director, 10% Owner | Sell | 1,033,300 | $22.14 | $22,877,262.00 | -11.5% | -8.4% | -29.2% | |
| May 14, 2024 | Patel Anish54 | Chief Operating Officer | Sale+OE | 1,107 | $25.00 | $27,675.00 | -100% | -10.7% | -16.7% | |
| May 9, 2024 | Patel Anish54 | Chief Operating Officer | Sale+OE | 260 | $25.06 | $6,515.50 | -100% | -9.3% | -22.9% |